A prospective study on serum antibodies against target antigens of bullous autoimmune diseases and genetic susceptibility.

Currently recruiting

About this study

This study aims to see how effective a new blood test (using a diagnostic test called EUROIMMUN biochip) is in diagnosing and monitoring autoimmune blistering skin diseases, in comparison to the standard blood test.

Anticipated enrolment close date: Ongoing

Contact Dermatology Research for more information.

Contact us to find out more about this research study, quoting reference number 2017.210

Who can take part

  • Diagnosis or suspected immunobullous disease

What's involved

  • Blood test a single visit
Person handling test tubes for research


All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.

This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.

The RMH Clinical Trials Centre
Clinical Trials Centre

The Clinical Trials Centre (CTC) is a dedicated, purpose-built space where we conduct clinical trials.

The CTC is located on Level 2 South. When you arrive, if you are unsure where to go, talk to one of our friendly volunteers or the information desk staff.